Page 11 - Domestic Markets

Investors should stick to stocks of firms focused on domestic market

Pharma firms can build brands and enjoy higher margins here

Growth in domestic market likely to provide booster dose for pharma stocks

The pharma sector, once considered a safe bet, has been trailing the benchmark indices for four years in a row

Markets slump 4% as investors sentiment remain sombre due to coronavirus

Indian indices fall 4%; gloom prevails in other global markets also after Trump's dire warning

Domestic markets stabilise after worst single-day slump in about 5 years

The Sensex ended 62 points higher at 35,697, while the Nifty ended little changed at 10,458

Overseas listings dry up as Indian companies eye domestic market

The decadal average of funds raised through this route is currently at its lowest on record

Domestic drug market stares at supply crisis due to coronavirus outbreak

Big pharma companies, however, said while it was true that formulation players would not rush to buy raw material, they could not afford losing customers.

Five reasons for the 900-point rally in the S&P BSE Sensex on Tuesday

All the Nifty sectoral indices are trading in the green. Nifty Bank, Nifty Financial Service, Nifty Metal, and Nifty Private Bank indexes gained over 2 per cent each

MNCs, domestic drug makers did equally well in terms of growth rate

The data shows that in the last 12 months, multinational drugmakers have also done equally well in the Indian market in terms of growth rate

NSE seeks cut in tax on capital market transactions to boost investment

Vikram Limaye said several taxes, including the securities transaction tax and the goods and services tax, are hurting investor participation

Mid, small caps see big surge after a year of sharp underperformance

Nifty Smallcap 100, Midcap 100 rally 3.9%, 2.4%

Market crash: Stick to export-focussed plays, large-caps, say analysts

Companies with quality management and strong earnings visibility were safer bets for investors